UPDATE (March 11–13, 2026): The US Trade Representative (USTR) has launched two Section 301 investigations into excess capacity and forced labor targeting China and other trade partners, in a move to ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results